Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-118882
Filing Date
2025-12-05
Accepted
2025-12-05 16:07:39
Documents
1
Period of Report
2025-12-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2532693-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2532693-3_4seq1.xml 4 3797
  Complete submission text file 0001104659-25-118882.txt   5670
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACTINIUM PHARMACEUTICALS, INC 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address
CICIC DRAGAN (Reporting) CIK: 0001565795 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 251553036